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CASE  REPORT
Introduction
Herbal remedies have been used worldwide for
thousands of years. However, hepatotoxicities of
medicinal plants have increasingly been reported
recently.1 The famous Chinese herbal medicine, xiao-
chai-hu-tang (syo-saiko-to in Japanese), is a mixture of
seven herbal components (bupleurum root, pinellia
tuber, scutellaria root, jujube fruit, ginseng root,
glycyrrhiza root, and ginger rhizome). It was first
prepared in the Han dynasty (BC 206–AD 220) to
treat patients with “Shaoyang syndromes” that were
likely linked to respiratory, gastrointestinal, and
hepatobiliary diseases. Today, it is widely used in
China, Taiwan, and Japan as the most popular herbal
remedy for liver disease.2 Unfortunately, hepatic injury
induced by this so-called hepatoprotective herb was
reported among 4 Japanese women.3 We report here
a Chinese woman who developed acute hepatitis from
using this herbal remedy. To the best of our knowledge,
Acute Hepatitis Induced by Chinese
Hepatoprotective Herb, Xiao-Chai-Hu-Tang
Li-Ming Hsu1, Yi-Shin Huang1*, Shyh-Haw Tsay2, Full-Young Chang1, Shou-Dong Lee1
1Division of Gastroenterology, Department of Medicine, 2Department of Pathology, Taipei Veterans General Hospital,
and National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
Xiao-chai-hu-tang (syo-saiko-to in Japanese) is a herbal remedy that has been widely used in China for treatment
of respiratory, hepatobiliary, and gastrointestinal diseases, particularly among patients with chronic liver disease.
However, its safety has recently been challenged. We, herein, report a Chinese patient with acute hepatitis induced
by this herb. A 52-year-old woman presented with weakness, fatigue, and tea-colored urine after continual consumption
of the decoction of xiao-chai-hu-tang for 1.5 months. Laboratory studies disclosed acute hepatitis even though all
of the viral hepatitis markers were negative. Liver biopsy also revealed a picture of acute hepatocellular hepatitis.
The symptoms improved after discontinuing the drug, and liver biochemical tests normalized 2 months later.
The case report reminds us of the probable adverse drug reaction of herbs, even in some that are claimed to have
hepatoprotective effects. [J Chin Med Assoc 2006;69(2):86–88]
Key Words: hepatotoxicity, herbal medicine, toxic hepatitis, xiao-chai-hu-tang
this is the first English report of hepatotoxicity induced
by this herb among Chinese consumers.
Case Report
A 52-year-old Chinese woman was admitted to our
hospital because of poor appetite, malaise, and fatigue
for 2 weeks. She had undergone laparoscopic
cholecystectomy for gall bladder stones and acute
cholecystitis at another hospital 4 months earlier.
Thereafter, she started a daily consumption of xiao-
chai-hu-tang prescribed by a traditional Chinese
medical practitioner for almost 1.5 months prior to
this admission. She decocted the dried herbal mixture
daily and then drank the extract twice a day. Two
weeks before admission, she noted progressive
development of poor appetite associated with nausea,
weakness, and fatigue. She denied taking any other
drug or drinking alcoholic beverages.
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Xiao-chai-hu-tang-induced acute hepatitis
On physical examination, she had no sign of chronic
liver disease. Laboratory profile on admission showed
elevated serum levels of aspartate aminotransferase
(AST) 862 IU/L (normal, 5–45 IU/L), alanine
aminotransferase (ALT) 2,028 IU/L (normal, 0–40
IU/L), a-glutamyl transpeptidase 482 IU/L (normal,
4–51 IU/L), alkaline phosphatase 213 IU/L (normal,
10–100 IU/L), total bilirubin 1.9 mg/dL (normal,
0.6–1.6 mg/dL), and direct bilirubin 0.7 mg/dL
(normal, 0–0.3 mg/dL). Other laboratory tests,
including complete blood count, serum urea nitrogen,
creatinine, glucose, electrolytes, total protein, albumin,
and ceruloplasmin were within normal range.
Coagulation studies were also unremarkable. All viral
hepatitis markers, including hepatitis B surface antigen,
IgM antibody to hepatitis B core antigen, IgM antibody
to hepatitis A virus, antibody to hepatitis C virus,
HCV-RNA, IgM antibody to cytomegalovirus, IgM
antibody to herpes simplex virus, and IgM antibody to
Epstein–Barr virus, were negative except for a positive
serum antibody to hepatitis B surface antigen. Her
serum antinuclear antibodies, antismooth muscle
antibodies, and antimitochondrial antibodies were
likewise negative.
A needle biopsy of the liver was performed 2 days
after admission. Histologically, the liver showed acute
hepatitis with many acidophilic bodies, centrilobular
necrosis, spotty necrosis, and focal fatty change.
Inflammatory infiltration was mainly mononuclear
cells without eosinophils. There was no portal fibrosis
(Figure 1). These histologic findings were compatible
with the hepatocellular pattern of acute drug-induced
hepatitis. After withdrawal of the herbs, her serum
levels of ALT and AST fell to 425 and 112 IU/L,
respectively, on the 11th day after admission and
normalized 2 months later (Figure 2).
Discussion
Xiao-chai-hu-tang is the most common traditional
drug in Asian countries for patients with chronic
hepatitis and liver cirrhosis.2 However, there has never
been concern for its safety until Itoh et al3 presented 4
women who suffered from xiao-chai-hu-tang-induced
acute liver injury. The latent period was 1.5–3 months,
with a mean of 2 months. Two of them were icteric and
the ALT levels ranged from 246 to 1,335 IU/L at the
initial presentation. All of the patients recovered without
complication and liver enzyme tests normalized within
3 months. Pathologic examination revealed acidophilic
degeneration, central lobular necrosis, spotty necrosis,
and microvesicular necrosis in addition to eosinophilic
infiltration in all specimens. Positive re-challenge with
xiao-chai-hu-tang confirmed the causality.
Our diagnosis of acute hepatitis associated with
xiao-chai-hu-tang was based on the exclusion of other
causes of hepatitis, the temporal relation of the drug
consumption, and the onset of acute hepatitis. Liver
biopsy in our patient revealed acute hepatitis without
eosinophilic infiltration. Therefore, hypersensitivity
reaction was not the possible mechanism of toxicity
because of the long latent period and the absence of
eosinophilic infiltration on liver biopsy. A direct
hepatotoxic effect or an idiosyncratic reaction to xiao-
chai-hu-tang may be the cause. However, re-challenge
with xiao-chai-hu-tang was not performed on our
patient because of ethical considerations.
Figure 1. Needle biopsy specimen of patient’s liver shows acute
hepatitis with acidophilic bodies, focal necrosis, and fatty change
(hematoxylin and eosin, = 160).
Figure 2. Sequential change of serum aminotransferase levels in
the patient with xiao-chai-hu-tang-induced acute hepatitis. AST =
aspartate aminotransferase; ALT = alanine aminotransferase.
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Xiao-chai-hu-tang is easily available in Taiwan as a
traditional decoction or a concentrated powder. In
general, the risk of herbal toxicity is higher in a
traditional decoction because of misidentification of
the correct plant materials, selection of a wrong part of
the prescriptive plant materials, inadequate storage,
contamination of the plant materials by various
chemicals, heavy metals, microorganisms, adulteration
during conditioning, and mislabeling of the final
products.4 Our patient decocted the herb by herself,
which obviously increased the risk of hepatotoxicity.
The main component of xiao-chai-hu-tang that
causes liver injury has been attributed to scutellaria.3
Scutellaria, commonly called skullcap, is a member of
the mint family. The root of Scutellaria baicalensis
(Chinese skullcap) is commonly used in traditional
Chinese herbal medicine.5 On the other hand, the
aerial part of Scutellaria lateriflora (American skullcap)
is used to treat anxiety disorder in Western countries.6
These are quite different and not interchangeable.7
The American skullcap used for relieving stress has
been implicated in the reported hepatotoxicity of 4
women.8 The skullcap diterpenoids derived from the
aerial part of Scutellaria lateriflora were shown to be
toxic to rat hepatocytes.9
In addition to hepatic injury, xiao-chai-hu-tang
also leads to acute lung injury, probably due to
allergic-immunologic mechanisms that increase the
incidence of lung injury when used together with
interferon-_.10–13 Skullcap was reported in a drug-
related pneumonitis in a Japanese man.14 Kiguchi et
al15 also reported a patient who developed severe
thrombocytopenia after taking xiao-chai-hu-tang for
treatment of chronic hepatitis. The jujube fruit of the
compound was suggested to have induced the
thrombocytopenia in this case.
Herbal medicine was long believed to be safe
without significant side effects. In Taiwan, about 40%
of patients with chronic liver or gastrointestinal diseases
use herbal preparations, but only 36% of them inform
their doctors.16 Therefore, a drug history in patients
with acute and chronic liver disease should include the
use of herbal medicine. Physicians should be aware of
the potential side effects of any herbal preparations.
This case report reminds us that even the most well-
known so-called hepatoprotective herb may have the
potential for hepatic injury.
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